Page last updated: 2024-08-17

levodopa and nad

levodopa has been researched along with nad in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (40.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Lovstad, RA	1
Birkmayer, JG; Birkmayer, W; Paletta, B; Vrecko, K	1
Birkmayer, GJ; Birkmayer, W	1
Debing, I; Ijzerman, AP; Vauquelin, G	1
Waring, P	1
Lange, KW; Riederer, P; Youdim, MB	1
Butler, J; Land, EJ; Prütz, WA	1
Danielczik, S; Gerstner, A; Häcker, R; Kuhn, W; Mattern, C; Müller, T; Przuntek, H; Winkel, R	1
Abdin, AA; Hamouda, HE	1

Reviews

1 review(s) available for levodopa and nad

Article	Year
Recent advances in pharmacological therapy of Parkinson's disease. Advances in neurology, 1993, Volume: 60 Topics: Antiparkinson Agents; Dopamine Agents; Droxidopa; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Levodopa; NAD; Neurologic Examination; Parkinson Disease; Receptors, Dopamine	1993

Trials

1 trial(s) available for levodopa and nad

Article	Year
Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:10 Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Dihydropteridine Reductase; Enzyme Activation; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; NAD; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Tyrosine 3-Monooxygenase	1996

Article

Year

Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.

Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:10

Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Dihydropteridine Reductase; Enzyme Activation; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; NAD; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Tyrosine 3-Monooxygenase

1996

Other Studies

8 other study(ies) available for levodopa and nad

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Effect of penicillamine on the conversion of dopa to dopachrome in the presence of tyrosinase or ceruloplasmin. Biochemical pharmacology, 1976, Mar-01, Volume: 25, Issue:5 Topics: Catechol Oxidase; Ceruloplasmin; Electrons; Free Radicals; In Vitro Techniques; Indolequinones; Indoles; Levodopa; Melanins; NAD; Oxidation-Reduction; Oxygen Consumption; Penicillamine; Quinones	1976
The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients. Advances in neurology, 1990, Volume: 53 Topics: Aged; Disability Evaluation; Humans; Infusions, Intravenous; Levodopa; Middle Aged; NAD; Neurologic Examination; Parkinson Disease	1990
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH). Acta neurologica Scandinavica. Supplementum, 1989, Volume: 126 Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Humans; Levodopa; Male; Middle Aged; NAD; NADP; Parkinson Disease	1989
Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity. Molecular pharmacology, 1988, Volume: 33, Issue:4 Topics: Animals; Cattle; Chloroquine; Chlorpromazine; Electron Transport; Kinetics; Levodopa; Melanins; Melanocytes; NAD; Oxidation-Reduction; Pirenzepine	1988
The time-dependent inactivation of human brain dihydropteridine reductase by the oxidation products of L-dopa. European journal of biochemistry, 1986, Mar-03, Volume: 155, Issue:2 Topics: Adrenochrome; Brain; Dihydropteridine Reductase; Disulfides; Electrophoresis, Polyacrylamide Gel; Humans; Hydrogen Peroxide; Indolequinones; Indoles; Levodopa; NAD; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Peroxidases; Quinones; Time Factors	1986
Photocatalytic and free radical interactions of the heterocyclic N-oxide resazurin with NADH, GSH, and Dopa. Archives of biochemistry and biophysics, 1996, Mar-15, Volume: 327, Issue:2 Topics: Catalysis; Dose-Response Relationship, Radiation; Free Radicals; Gamma Rays; Glutathione; Hydroxyl Radical; Indicators and Reagents; Kinetics; Levodopa; NAD; Oxazines; Oxidation-Reduction; Photochemistry; Spectrophotometry; Time Factors; Xanthenes	1996
Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Neuropharmacology, 2008, Volume: 55, Issue:8 Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Levodopa; Mitochondria; NAD; Neurons; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Rats; Rotenone; Spectrophotometry; Ubiquinone; Ultrasonography; Vitamins	2008